Indefinite Delivery Contract HHSD200201033745I
Award Date 3/15/10
Last Date to Order 2/28/11
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to GlaxoSmithKline Holdings (Americas) Inc. The contract has a ceiling value of $20,661,104.25 and a period of performance from March 15, 2010 to February 28, 2011. The contract appears to be for the procurement of flu vaccine products and related services as part of the CDC's Vaccine for Children (VFC) program. While the exact scope...
- This indefinite delivery contract, awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, aims to procure products and services related to the FLU 2009 Vaccine Formal Agreement (FLU 2009 VFA) program. The single-award contract, which has a ceiling value of $18,843,626.15 and a period of performance ending on February 28, 2010, was awarded to GlaxoSmithKline Holdings (Americas) Inc. on April 24, 2009. The contract does not...
- This Indefinite Delivery Contract, awarded to GlaxoSmithKline, LLC on December 31, 2024, provides the Centers for Disease Control and Prevention with adult influenza vaccines through February 28, 2026, under the 2025-6 ADULT FLU VACCINES procurement. The contract carries a ceiling value of $13.9 million and was awarded as a multiple-award indefinite delivery vehicle without set-aside designations. As the prime contractor, GlaxoSmithKline will supply flu vaccines to support the CDC's immunization...
- The Centers for Disease Control and Prevention (CDC) awarded a single award Indefinite Delivery Contract to Glaxosmithkline, LLC, a pharmaceutical company, to procure pediatric influenza vaccines for the 2022-2023 season. The contract has a potential value of $168,590,000 and a period of performance from the date of award through February 28, 2023. The original solicitation sought between 100 doses and 50 million doses of pediatric influenza vaccine to be delivered to CDC distribution centers in...
- The Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery/Indefinite Quantity contract to GlaxoSmithKline, LLC on December 31, 2025, for the provision of adult influenza vaccines under the major program code VACCINES. This multiple-award contract, with no set-aside designation, carries a ceiling value of $13.9 million and extends through February 28, 2027. The contract supports the CDC's immunization programs and public health objectives by establishing a vehicle...
- This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC as the prime contractor. The contract, valued at up to $1.25 billion, is part of the Vaccines for Children (VFC) 2015 program and provides for the delivery of various vaccines and pharmaceutical products to support federal immunization and disease prevention initiatives. Key products and services included under this multiple award IDV contract include seasonal influenza...
- This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to MedImmune, LLC, a for-profit organization. The single-award IDC has a ceiling value of $373,407,823 and a period of performance ending on February 28, 2011. The contract aims to procure flu vaccine products and related services as part of the CDC's Vaccine for Children (VFC) program in support of the 2010 flu season. The...
- The Centers for Disease Control and Prevention (CDC), operating through its Pittsburgh office, awarded a Multiple Award Indefinite Delivery Contract to GlaxoSmithKline, LLC for the Vaccines for Children (VFC) program with a ceiling value of $1.49 billion and a performance period from April 1, 2025, through March 31, 2026. This civilian contract, which received no set-aside designation, procures standard commercial pediatric vaccines to support immunization efforts for eligible populations,...
- Glaxosmithkline, LLC has been awarded a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the Centers for Disease Control and Prevention (CDC) to supply pediatric influenza vaccines for children ages 0-18 years through the Vaccine for Children (VFC) program. The contract, valued at $167.4 million with a ceiling and an ultimate completion date of February 28, 2027, was awarded on December 31, 2025, following a competitive solicitation posted on August 14, 2025. The VFC...
- The Indefinite Delivery Contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh provides adult flu vaccines for the 2023-2024 period. Glaxosmithkline, LLC was awarded a multiple award contract with a potential value of $13.9 million to deliver flu vaccines through February 2028 under associated task orders or price lists. The solicitation aimed to procure adult flu vaccines to support the Centers for Disease Control and Prevention's...